Post-mortem ABCB1 genotyping reveals an elevated toxicity for female digoxin users

International Journal of Legal Medicine

Volumn 125, Issue 2, 2011, Pages 265-269

  Neuvonen, Anu M ^a   Palo, Jukka U ^a   Sajantila, Antti ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

ABCB1; Digoxin; Gene; Pharmacogenetics; Single nucleotide polymorphism

Indexed keywords

ABCB1 PROTEIN, HUMAN; DIGOXIN; GLYCOPROTEIN P;

ARTICLE; FEMALE; FINLAND; FORENSIC GENETICS; GENE FREQUENCY; GENETICS; GENOTYPE; HUMAN; MALE; METABOLISM; PHARMACOGENETICS; POPULATION GENETICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

DIGOXIN; FEMALE; FINLAND; FORENSIC GENETICS; GENE FREQUENCY; GENETICS, POPULATION; GENOTYPE; HUMANS; MALE; P-GLYCOPROTEIN; PHARMACOGENETICS; POLYMORPHISM, SINGLE NUCLEOTIDE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEX FACTORS;

EID: 79955898897     PISSN: 09379827     EISSN: 14371596     Source Type: Journal    
DOI: 10.1007/s00414-011-0550-0     Document Type: Article

References (35)

1. The Digitalis Investigation Group (1997) The effect of digoxin on mortality and morbidity in patients with heart failure. New Engl J Med 336(8):525-533
2. Launiainen T, Vuori E, Ojanperä I (2009) Prevalence of adverse drug combinations in a large post-mortem toxicology database. Int J Legal Med 123(2):109-115
3. Thiebaut F, Tsuruo T, Hamada H, Gottesman MM, Pastan I, Willingham MC (1987) Cellular localization of the multidrugresistance gene product P-glycoprotein in normal human tissues. Proc Natl Acad Sci USA 84(21):7735-7738
4. Hoffmeyer S, Burk O, von Richter O et al (2000) Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with Pglycoprotein expression and activity in vivo. Proc Natl Acad Sci USA 97(7):3473-3478 (Pubitemid 30183327)
5. Sakaeda T, Nakamura T, Horinouchi M et al (2001) MDR1 genotype-related pharmacokinetics of digoxin after single oral administration in healthy Japanese subjects. Pharm Res 18 (10):1400-1404 (Pubitemid 32977244)
6. Johne A, Köpke K, Gerloff T et al (2002) Modulation of steadystate kinetics of digoxin by haplotypes of the P-glycoprotein ABCB1 gene. Clin Pharmacol Ther 72(5):584-594 (Pubitemid 36237730)
7. Verstuyft C, Schwab M, Schaeffeler E et al (2003) Digoxin pharmacokinetics and MDR1 genetic polymorphisms. Eur J Clin Pharmacol 58(12):809-812 (Pubitemid 36577811)
8. Morita Y, Sakaeda T, Horinouchi M (2003) MDR1 genotyperelated duodenal absorption rate of digoxin in healthy Japanese subjects. Pharm Res 20(4):552-556 (Pubitemid 36438897)
9. Chowbay B, Li H, David M, Cheung YB, Lee EJD (2005) Metaanalysis of the influence of MDR1 C3435T polymorphism on digoxin pharmacokinetics and MDR1 gene expression. Brit J Clin Pharmacol 60(2):159-171 (Pubitemid 41075901)
10. Aarnoudse AJ, Dieleman JP, Visser LE et al (2008) Common ATPbinding cassette B1 variants are associated with increased digoxin serum concentration. Pharmacogenet Genomics 18(4):299-305 (Pubitemid 351367523)
11. Böttiger Y, Laine K, Andersson ML et al (2009) SFINX-a drugdrug interaction database designed for clinical decision support systems. Eur J Clin Pharmacol 65(6):627-633
12. PHASE software for haplotype estimation. Accessed April 2010, at http://stephenlab.uchicago.edu/software.html
13. Excoffier L, Laval G, Schneider S (2005) Arlequin ver. 3.0: an integrated software package for population genetics data analysis. Evol Bioinform Online 1:47-50
14. Lao O, Lu TT, Nothnagel M et al (2008) Correlation between genetic and geographic structure in Europe. Curr Biol 18 (16):1241-1248
15. Keskitalo JE, Kurkinen KJ, Neuvonen PJ, Niemi M (2008) ABCB1 haplotypes differentially affect the pharmacokinetics of the acid and lactone forms of simvastatin and atorvastatin. Clin Pharmacol Ther 84(4):457-461
16. Palo JU, Hedman M, Ulmanen I, Lukka M, Sajantila A (2007) High degree of Y-chromosomal divergence within Finland- forensic aspects. Forensic Sci Int-Gen 1:120-124 (Pubitemid 46760400)
17. Salmela E, Lappalainen T, Fransson I et al (2008) Genome-wide analysis of single nucleotide polymorphisms uncovers population structure in Northern Europe. PLoS ONE 3(10):e3519
18. Rathore SS, Wang Y, Krumholz HM (2002) Sex-based differences in the effect of digoxin for the treatment of heart failure. N Engl J Med 347(18):1403-1411 (Pubitemid 35239712)
19. Aarnoudse AL, Dieleman JP, Stricker BH (2007) Age- and gender-specific incidence of hospitalisation for digoxin intoxication. Drug Saf 30(5):431-436 (Pubitemid 46740339)
20. Nicolson TJ, Mellor HR, Roberts RRA (2009) Gender differences in drug toxicity. Trends Pharmacol Sci 31(3):108-114
21. Schuetz EG, Furuya KN, Schuetz JD (1995) Interindividual variation in expression of P-glycoprotein in normal human liver and secondary hepatic neoplasms. J Pharmacol Exp Ther 275(2):1011-1018 (Pubitemid 26023635)
22. Schwartz JB (2007) The current state of knowledge on age, sex, and their interactions on clinical pharmacology. Clin Pharmacol Ther 82(1):87-96 (Pubitemid 46944201)
23. Gaikovitch EA, Cascorbi I, Mrozikiewicz PM et al (2003) Polymorphisms of drug-metabolizing enzymes CYP2C9, CYP2C19, CYP2D6, CYP1A1, NAT2 and of P-glycoprotein in a Russian population. Eur J Clin Pharmacol 59(4):303-312 (Pubitemid 37100349)
24. Goreva OB, Grishanova AY, Domnikova NP, Mukhin OV, Lyakhovich VV (2004) MDR1 gene C1236T and C6+139T polymorphisms in the Russian population: associations with predisposition to lymphoproliferative diseases and drug resistance. Bull Exp Biol Med 138(4):404-406 (Pubitemid 40403463)
25. Green H, Söderkvist P, Rosenberg P, Horvath G, Peterson C (2006) MDR1 single nucleotide polymorphisms in ovarian cancer tissue: G2677T/A correlates with response to paclitaxel chemotherapy. Clin Cancer Res 12(3):854-859 (Pubitemid 43259868)
26. Larsen UL, Hyldahl Olesen L, Guldborg-Nyvold C et al (2007) Human intestinal P-glycoprotein activity estimated by the model substrate digoxin. Scand J Clin Lab Invest 67(2):123-134 (Pubitemid 46410602)
27. Pechandova K, Buzkova H, Slanar O, Perlik F (2006) Polymorphisms of the MDR1 gene in the Czech population. Folia Biol (Praha) 52(6):184-189 (Pubitemid 46020161)
28. Urayama KY, Wiencke JK, Buffler PA, Chokkalingam AP, Metayer C, Wiemels JL (2007) MDR1 gene variants, indoor insecticide exposure, and the risk of childhood acute lymphoblastic leukemia. Cancer Epidemiol Biomark Prev 16(6):1172-1177 (Pubitemid 46984955)
29. Song P, Lamba JK, Zhang L et al (2006) G2677T and C3435T genotype and haplotype are associated with hepatic ABCB1 (MDR1) expression. J Clin Pharmacol 46(3):373-379 (Pubitemid 43260324)
30. Gonzalez TP, Mucenic T, Brenol JCT, Xavier RM, Scheingold M, Chies JAB (2008) ABCB1 C1236T, G2677T/A, and C3435T polymorphisms in systemic lupus erythematosus patients. Braz J Med Biol Res 41(9):769-772
31. Chelule PK, Gordon M, Palanee T, Mosam A, Coovadia HM, Cassol S (2003) MDR1 and CYP3A4 polymorphisms among African, Indian, and white populations in KwaZulu-Natal, South Africa. Clin Pharmacol Ther 74(2):195-196 (Pubitemid 36951818)
32. Ameyaw MM, Regateiro F, Li T et al (2001) MDR1 pharmacogenetics: frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity. Pharmacogenetics 11(3):217-221 (Pubitemid 32319871)
33. Chen B, Fang J, Zhang W, Jin Z, Yu Z, Cai W (2009) Detection of C1236T, G2677T, and C3435T polymorphism of MDR1 by amplification refractory mutation system PCR. J Clin Lab Anal 23(2):110-116
34. Komoto C, Nakamura T, Sakaeda T et al (2006) MDR1 haplotype frequencies in Japanese and Caucasian, and in Japanese patients with colorectal cancer and esophageal cancer. Drug Metab Pharmacokinet 21(2):126-132
35. Ryu HC, Kwon HY, Choi IK, Rhee DK (2006) Analyses of single nucleotide polymorphisms and haplotype linkage of the human ABCB1 (MDR1) gene in Korean. Arch Pharm Res 29(12):1132-1139